Durect’s post-op painkiller splits FDA advisory panelAs the US opioid addiction crisis continues, it seems the FDA is less than convinced about the new Share XDurect’s post-op painkiller splits FDA advisory panelhttps://pharmaphorum.com/news/durects-post-op-painkiller-splits-fda-advisory-panel/
